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Abstract
Background
Chagas cardiomyopathy (CDC) is associated with a poor prognosis compared to other car-
diomyopathies. Speckle tracking echocardiography (STE), which provides direct assess-
ment of myocardial fiber deformation, may be useful in predicting prognosis.
Objective
This study assessed STE in CDC and compared with idiopathic cardiomyopathy (IDC), and
also examined the incremental prognostic information of STE over left ventricular ejection
fraction (LVEF) in these patients.
Methods
We enrolled 112 patients, age of 56.7 ± 11.8 years, 81 with CDC and 31 with IDC. STE indi-
ces were obtained at baseline in all patients. The endpoint was a composite of death, hospi-
talization for heart failure, or need for heart transplantation.
Results
Patients with IDC had worse LV systolic function compared to CDC, with LVEF of 34.5% vs
41.3%, p = 0.004, respectively. After adjustment for LVEF, there were no differences in STE
values between CDC and IDC. During a median follow-up of 18.2 months (range, 11 to 22),
26 patients met the composite end point (24%). LV longitudinal strain was a strong predictor
of adverse events, incremental to LVEF and E/e’ ratio (HR 1.463, 95% CI 1.130–1.894; p =
PLOS ONE | https://doi.org/10.1371/journal.pone.0221028 August 22, 2019 1 / 14
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Santos Junior OR, da Costa Rocha MO,
Rodrigues de Almeida F, Sales da Cunha PF, Souza
SCS, Saad GP, et al. (2019) Speckle tracking
echocardiographic deformation indices in Chagas
and idiopathic dilated cardiomyopathy: Incremental
prognostic value of longitudinal strain. PLoS ONE
14(8): e0221028. https://doi.org/10.1371/journal.
pone.0221028
Editor: Otavio Rizzi Coelho-Filho, Faculty of Medical
Science - State University of Campinas, BRAZIL
Received: March 4, 2019
Accepted: July 29, 2019
Published: August 22, 2019
Copyright: © 2019 Santos Junior et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data cannot be
shared publicly because the data are confidential
and participants did not consent to have data
publicly shared. Data are available from the "Comitê
de E´tica e Pesquisa Humana Institutional" Data
Access / Ethics Committee (contact via
coep@prpq.ufmg.br) for researchers who meet the
criteria for access to confidential data.
0.004). The risk of cardiac events increased significantly in patients with GLS > - 12% (log-
rank p = 0.035).
Conclusions
STE indices were abnormal in patients with dilated cardiomyopathy, without differences
between CDC and IDC. LV longitudinal strain was a powerful predictor of outcome, adding
prognostic information beyond that provided by LVEF and E/e’ ratio.
Introduction
Chagas disease continues to be one of the most prevalent infectious diseases in Latin America,
and has become a public health concern in non-endemic countries [1, 2]. Chagas cardiomyop-
athy constitutes the most serious manifestation of the disease, as a consequence of chronic
myocarditis that leads to myocardial dysfunction and conduction-system defects [3, 4]. Chagas
cardiomyopathy is associated with poor prognosis with higher mortality rates compared with
other causes of heart failure [5–8]. A previous study showed that the patients with Chagas
dilated cardiomyopathy (CDC) had worse survival than those with idiopathic dilated cardio-
myopathy (IDC), independent of well-established prognostic of outcome in heart failure [8].
The structural derangement associated with intense collagen deposition within the left ven-
tricle may play a role in determining the prognosis in Chagas cardiomyopathy [9]. Indeed, pre-
vious studies with cardiac magnetic resonance (CMR) have demonstrated that myocardial
fibrosis is associated with impairment of systolic function, abnormal remodeling, and
increased ventricular stiffness [10, 11]. Recently, a study demonstrated that left ventricular
(LV) fibrosis assessed by CMR is independently related to major advserse cardiac events in
patients with Chagas disease [12]
The pattern of myocardial fibrosis, however, varies according to the specific cause of cardio-
myopathy[13]. Different types of myocardial fibrosis have been described according to the
myopathic disease process [13]. In patients with Chagas disease, replacement myocardial
fibrosis appears to be the predominant form, whereas in IDC diffuse interstitial fibrosis
appears to be the major form [9, 10, 13].
Speckle tracking echocardiography (STE), a method that allows measurement of myocar-
dial strain, has been utilized to demonstrate impaired cardiac function secondary to the degree
of cardiac fibrosis [14]. However, the studies addressing the association of STE and myocardial
fibrosis in Chagas disease have demonstrated controversial results [15, 16]. Gomes et al
showed that patients with fibrosis on CMR imaging had lower global longitudinal, circumfer-
ential, and radial LVLV strain compared to controls without cardiac fibrosis despite similar
LV ejection fraction [16]. Macedo et al also demonstrated a high correlation between longitu-
dinal global speckle tracking strain with severity of myocardial fibrosis assessed by CMR in a
cohort of 58 patients with different forms of chronic Chagas disease [15]. In their study, myo-
cardial fibrosis directly correlated with LV ejection fraction. Longitudinal strain had no incre-
mental role on the prediction of myocardial fibrosis, even in the patients with ventricular
dysfunction [15].
Therefore, the present study was designed to assess differences in strain in patients with
dilated cardiomyopathy due to Chagas disease versus idiopathic dilated cardiomyopathy and
to characterize difference between idiopathic dilated cardiomyopathy with similar demo-
graphic characteristics. In addition, we aimed to determine the independent prognostic value
Longitudinal strain in dilated cardiomyopathy
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of global longitudinal strain in the overall patient population with Chagas and non-Chagas
dilated cardiomyopathy.
Methods
Study population
A total of 184 consecutive patients who were referred to our centre for clinical symptoms of
heart failure due to Chagas or idiopathic cardiomyopathy between September 2015 to October
2016 were prospectively enrolled. The patients were considered eligible for the study if they
had a diagnosis of Chagas dilated cardiomyopathy (CDC) as defined by LV enlargement with
systolic function impairment due to Chagas disease, defined as LV ejection fraction below 50%
assessed by 2D echocardiography, or controls i.e. idiopathic dilated cardiomyopathy (IDC)
characterized by dilated LV with systolic dysfunction, and negative serological tests for Chagas
disease in the absence of abnormal loading conditions or coronary artery disease sufficient to
cause global systolic impairment [17].
Exclusion criteria included the presence of atrial fibrillation, and other cardiac or systemic
diseases that may affect ventricular function, especially systemic hypertension, and rheumatic
valve disease. The patients with symptoms suggestive of ischemic heart disease with risk factors
for atherosclerosis underwent coronary angiography for rule out ischemic heart disease.
Patients who had a pacemaker or an implanted cardioverter-defibrillator also were excluded.
Based on these inclusion and exclusion criteria, a final cohort of 112 was enrolled in the
study. All patients were clinically stable on guideline based heart failure therapy. The study
protocol was approved by the institutional review board.
Echocardiographic evaluation
A standard comprehensive echocardiography was performed in all patients (Vivid Q, GE). All
images were stored digitally and analysed off-line with EchoPac software (GE Medical). Quan-
tification of cardiac chamber size and function were obtained in accordance with ASE guide-
lines [18]. The echocardiographic measurements were performed by one independent
observer who was blinded to the etiology of the cardiomyopathy. Values from 3 consecutive
cardiac cycles were measured and averaged.
LV diastolic function was assessed by pulsed-wave Doppler examination of mitral inflow
and by tissue Doppler imaging (TDI). Peak systolic velocities (S’) as well as early diastolic (e’)
and late diastolic (A’) velocities were measured at the medial and lateral border of the mitral
annulus in the apical four-chamber view [19]. The E/e’ ratio was then calculated using the
average of the septal and lateral e’.
The continuous-wave Doppler tricuspid regurgitant velocity was used to estimate systolic
pulmonary artery pressure (SPAP) using the simplified Bernoulli equation. RV function was
also assessed using tissue Doppler imaging [20].
Assessment of speckle tracking strain
Images of the LV in the apical 4-, 2- and 3-chamber views were obtained for analysis, as previ-
ously described.[21] The LV was divided into 18 segments and, by using a dedicated software
package (Echopac PC, Version 7.0.X, GE Healthcare, Fairfield, CT), 2D LV longitudinal strain
was obtained for each segment[22]. Longitudinal systolic strain was determined from apical
views (Fig 1). The value of global longitudinal strain was obtained by averaging all LV seg-
ments, which was used for comparisons with the IDC controls (Fig 2).
Longitudinal strain in dilated cardiomyopathy
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Radial (RS) and circumferential strain (CS) were obtained in all 18 segments of the three
short-axis views. The average of peak systolic radial and circumferential strain values was cal-
culated to derive the global LV radial and circumferential strain and strain rates (Figs 3 and 4).
LV twist was calculated as the difference between apical and basal rotations at each corre-
sponding time point.
RV strain was assessed from a dedicated apical focused four-chamber view with the sample
areas placed in the basal, mid, and apical segments of the RV free wall and ventricular septum.
A region of interest was manually drawn to include the entire myocardial wall and to exclude
the pericardium. Patients in which>2 segments per ventricle revealed inadequate tracking
despite attempts to readjust the region of interest position were excluded from speckle tracking
strain analysis.
Fig 1. Peak systolic longitudinal strain of the left ventricle obtained at apical 4-chamber view. Parametric (color-
coded) display of end-systolic strain (left upper panel); segmental peak systolic strain values are indicated (left lower
panel); strain-time curves: colored curves displaying segmental strain (right upper panel); M-mode representation of
peak systolic strain (right lower panel).
https://doi.org/10.1371/journal.pone.0221028.g001
Fig 2. Left ventricular strain curves and bull’s eye plots. LV longitudinal strain curves derived from speckle-tracking
analysis for each LV segment at apical 4-chamber view (left panel), paraesternal long-axis view (left lower panel),
2-chamber view (right upper panel), and bull’s eye” plot (right lower panel).
https://doi.org/10.1371/journal.pone.0221028.g002
Longitudinal strain in dilated cardiomyopathy
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Endpoint definition
The endpoint was a composite endpoint of death, heart failure hospitalization, or cardiac
transplantation. Follow-up data were obtained during clinical follow-up appointment or tele-
phone interviews. To satisfy the assumption of the independence of events, hospitalization for
heart failure, during which cardiac transplant was recommended or patient died, was not
defined as a separate endpoint.
Statistical analysis
Categorical variables were presented as numbers and percentages, whereas continuous vari-
ables were expressed as mean ± standard deviation (SD). The measurements of patients with
CDC and IDC were compared using Chi-square test, unpaired Student’s t-test or Mann-
Fig 3. Radial strain of the left ventricle selected at the papillary muscles. The myocardium was divided into six
segments (left upper panel); segmental strain graphically displayed (left lower panel); colored curves are outlined (right
upper panel); M-mode color-coded display of peak systolic strain (right lower panel).
https://doi.org/10.1371/journal.pone.0221028.g003
Fig 4. Left ventricular circumferential strain at the papillary muscles, with tracked of the six segments (left upper
panel); M-mode representation of peak systolic strain (left lower panel); segmental end-systolic strain graphically
displayed (left panel).
https://doi.org/10.1371/journal.pone.0221028.g004
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Whitney test, as appropriate. Multivariable Cox proportional hazards analysis was used to
identify variables associated with adverse events, considering the time until the occurrence of
an endpoint of interest.
The potential predictive variables of outcome included in the Cox analysis were NYHA
functional class, LV ejection fraction, LA volume index, E/e’ ratio, longitudinal RV strain, and
global longitudinal strain. In order to prevent overfitting, the shrinkage factor of regression
coefficients was applied after the model has been fitted by traditional methods [23].
All analyses were performed using SPSS 21.0 (SPSS Inc, Chicago, IL)
Results
Baseline clinical characteristics
Of the 112 patients recruited, 81 patients had CDC whereas 31 had IDC. The mean age was
56.7 ± 11.8 years, and 63 patients were men (56%). The baseline clinical characteristics of the
study population, comparing Chagas with idiopathic cardiomyopathy, are summarized in
Table 1. Most of the patients (72%) were in NYHA functional class II and 15 patients were
class I at the time of inclusion in the study. One hundred and seven patients (96%) were on
angiotensin-converting enzyme inhibitors or angiotensin receptor blockers therapy, 77 (69%)
beta-blockers, 68 (61%) diuretics, and 21 (19%) anticoagulants.
The demographic features were similar between the groups. However, patients with IDC
presented more frequently in class III with evidence of systemic congestion than patients with
CDC. Similarly, diuretics use was more frequent in IDC, which also reflects the heart failure
severity.
Right bundle-branch block was more frequent in the patients with Chagas than in those
with IDC (57% vs 10%; p <0.001). The proportion of patients with premature ventricular con-
tractions was similar between the groups. No difference was observed in regard to other ECG
variables.
Echocardiographic measurements
Echocardiographic parameters to measure LV function according to the types of cardiomyop-
athy are shown on Table 1. Patients with IDC had worse LV systolic function compared to
CDC, with ejection fraction of 34.5% vs 41.3%, p = 0.004, respectively. There was no difference
in the indexes of LV diastolic function in patients with CDC and IDC. Additionally, RV func-
tion was similar between the patients, except RV end-diastolic volume that was higher in IDC
than CDC (Table 1). LV apical aneurysm was found in 14 patients (17%) with thrombi in 5
patients (6%), only in patients with CDC. Segmental wall motion abnormalities were detected
in 40 patients (49%) with CDC and in 3 (10%) with IDC, being more frequent in inferolateral
and inferior walls.
Speckle tracking echocardiographic strain
Global LV longitudinal strain was lower in patients with IDC than CDC (10.5 ± 4.4 vs
12.5 ± 4.2; p = 0.032, respectively), especially in the inferoseptal and anteroseptal walls
(Table 2). Circumferential strain was reduced only in anteroseptal wall in patients with ICD
compared to CDC, with no difference in the global circumferential and radial strain. Similarly,
RV longitudinal strain did not differ between groups.
Since IDC patients had lower LV ejection fraction than CDC, a sub-analysis was performed
selecting patients with similar degree of LV systolic dysfunction (LV ejection fraction� 35%;
46 patients). The results showed no differences in global longitudinal (7.6 ± 2.8 vs 7.8 ± 1.9;
Longitudinal strain in dilated cardiomyopathy
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p = 0.721), radial (12.3 ± 7.2 vs 11.0 ± 5.2; p = 0.523) or circumferential (7.2 ± 3.2 vs 6.5 ± 3.6;
p = 0.567) strain in patients with IDC compared with CDC, respectively. Similarly, RV longitu-
dinal strain was 11.3 ± 5.1 in IDC and 12.9 ± 4.9 in CDC (p = 0.331).
Predictors of outcome
During a median follow-up of 18.2 months (range, 11 to 22), 26 events occurred (14 heart fail-
ure hospitalization, 8 cardiac deaths, and 4 cardiac transplant). Of patients with idiopathic car-
diomyopathy, 6 events (19%) occurred compared with 20 (25%) in Chagas cardiomyopathy
(P = 0.508).
Table 1. Clinical features of the patients stratified according to underlying cause of cardiomyopathy.
Variable� Chagas cardiomyopathy
(n = 81)
Idiopathic cardiomyopathy
(n = 31)
P value
Age (years) 56.9 ± 10.5 56.1 ± 4.8 0.752
Male (n/%) 48 (59) 15 (48) 0.299
Body surface area (m2) 1.72 ± 0.2 1.79 ± 0.2 0.091
NYHA class I 12 (15) 3 (10) 0.021
II-III 69 (85) 28 (90)
Right ventricular failure† 9 (11) 9 (29) 0.021
Heart rate (bpm) 69.3 ± 13.7 71.4 ± 10.5 0.430
SBP (mmHg) 117.9 ± 15.7 113.2 ± 13.7 0.145
DBP (mmHg) 77.2 ± 11.1 72.1 ± 9.5 0.025
Medications
ACE inhibitors 35 (43) 19 (61) 0.096
Diuretics 43 (53) 25 (81) 0.009
Beta-blockers 51 (63) 26 (84) 0.041
Amiodarone 21 (26) 3 (10) 0.073
Anticoagulants 15 (19) 6 (19) 0.557
Echocardiographic parameters
LVDd (mm) 59.3 ± 9.3 62.5 ± 11.9 0.135
LVSd (mm) 46.9 ± 9.9 52.2 ± 10.9 0.016
LVEF (%) 41.25 ± 9.05 34.48 ± 11.18 0.004
LA volume index (mL/m2) 36.4 ± 15.0 41.1 ± 19.1 0.175
E (cm/s) 68.24 ± 27.15 73.52 ± 28.62 0.381
A (cm/s) 74.88 ± 21.34 71.39 ± 26.09 0.510
DT (ms) 218.10 ± 77.15 186.26 ± 90.46 0.057
E/e’ ratio 12.34 ± 5.91 14.99 ± 8.12 0.106
PASP (mmHg) 33.5 ± 27.3 37.1 ± 12.3 0.492
Peak systolic velocity (cm/s)†† 11.6 ± 2.9 11.4 ± 3.3 0.735
�Variables are expressed as mean value ± SD or number (percentage) of patients.
†: Manifestations of right-sided heart failure.
††Peak systolic velocity at the tricuspid annulus
A = late diastolic transmitral flow velocity; BSA = body surface area; DBP = diastolic blood pressure; DT = deceleration time; E = early diastolic transmitral flow velocity;
e’ = early diastolic mitral annular velocity at septal and lateral mitral annulus, E/e’ = ratio of the early diastolic transmitral flow velocity to early diastolic mitral annular
velocity (average at septal and lateral mitral annulus); LA = left atrial; LVDd = left ventricular end-diastolic diameter; LVEF = left ventricular ejection fraction;
LVSd = left ventricular end-systolic diameter; NYHA = New York Heart Association; PASP = pulmonary artery systolic pressure; RV = right ventricular; RVEF = right
ventricular ejection fraction; SBP = systolic blood pressure; TR = tricuspid regurgitation.
https://doi.org/10.1371/journal.pone.0221028.t001
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By univariate analysis by Cox model, several variables were associated with poor outcome
(Table 3). In the multivariate analysis including the entire cohort, the independent predictors
of adverse events were LV ejection fraction (Hazard ratio [HR] 0.839; 95% confidence interval
[CI] 0.760–0.925; p<0.001), E/e’ ratio (HR 1.060; 95% CI 1.015–1.108; p = 0.008), and LV lon-
gitudinal strain (HR 1.365; 95% CI 1.106–1.686; p = 0.004) (Table 4).
The AUC increased slightly with the inclusion of LV strain in the model, from 0.818 (95%
CI 0.732–0.905) to 0.839 (95% CI 0.757–0.921).
The risk of cardiac events increased significantly in patients with GLS > - 12% (log-rank
p = 0.035) (Fig 5).
Table 2. Ventricular speckle tracking strain of patients with Chagas cardiomyopathy compared to idiopathic cardiomyopathy.
Walls� Chagas cardiomyopathy
(n = 81)
Idiopathic cardiomyopathy
(n = 31)
P value
LV Longitudinal strain (%)
Antero-septal 12.07 ± 5.02 9.01 ± 5.16 0.005
Anterior 12.55 ± 4.43 10.61 ± 5.01 0.064
Antero-lateral 11.85 ± 5.35 10.66 ± 5.26 0.295
Infero-lateral 11.14 ± 5.73 11.20 ± 4.98 0.956
Inferior 13.12 ± 5.34 10.59 ± 5.59 0.024
Infero-septal 14.34 ± 5.09 9.72 ± 5.69 <0.001
Global strain 12.46 ± 4.22 10.49 ± 4.43 0.032
Strain rate (s-1) 0.73 ± 0.23 0.71 ± 0.28 0.672
LV Radial strain (%)
Antero-septal 14.76 ± 7.51 14.03 ± 9.49 0.701
Anterior 15.51 ± 8.21 16.44 ± 9.71 0.615
Antero-lateral 16.28 ± 8.18 18.34 ± 9.25 0.254
Infero-lateral 16.35 ± 8.56 18.70 ± 9.29 0.206
Inferior 16.28 ± 8.66 17.17 ± 9.34 0.636
Infero-septal 15.72 ± 8.30 15.00 ± 9.34 0.691
Global strain 15.82 ± 7.83 16.61 ± 9.14 0.653
Strain rate (s-1) 0.73 ± 0.23 0.71 ± 0,28 0.672
Twist 7.40 ± 4.23 8.85 ± 5.60 0.200
LV Circumferential strain (%)
Antero-septal 14.49 ± 6.32 11.65 ± 5.76 0.027
Anterior 12.61 ± 5.57 10.78 ± 4.35 0.072
Antero-lateral 10.36 ± 4.30 11.40 ± 3.74 0.216
Infero-lateral 10.15 ± 4.29 11.84 ± 4.55 0.069
Inferior 10.54 ± 4.95 10.86 ± 3.99 0.721
Infero-septal 14.84 ± 7.20 12.26 ± 5.70 0.052
Global strain 10.38 ± 4.05 9.30 ± 3.77 0.202
Strain rate (s-1) 0.96 ± 0.27 1.02 ± 0.32 0.375
RV Longitudinal Strain (%)
Septal wall 11.5 ± 4.0 10.1 ± 4.9 0.135
RV free wall 18.5 ± 7.1 15.8 ± 5.7 0.064
Global RV strain 14.9 ± 4.8 12.9 ± 4.9 0.052
Strain rate (s-1) 1.02 ± 0.34 0.96 ± 0.34 0.414
�The table presents absolute values of strain.
LV = left ventricular; RV = right ventricular
https://doi.org/10.1371/journal.pone.0221028.t002
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Discussion
This study evaluated the utility of strain in patients with dilated cardiomyopathy and sought to
identify differences in strain pattern and values according to the underlying cause of the car-
diomyopathy. Speckle tracking echocardiographic deformation indices are abnormal in
patients in patients with dilated cardiomyopathy. Specifically, myocardial contractility by STE
in patients with CDC does not appear to be more impaired compared with IDC with similar
LV ejection fraction. Global LV longitudinal strain is associated with cardiac events in patients
with dilated cardiomyopathy, regardless of the etiology of the cardiomyopathy, independent of
other parameters of poor prognosis including LV ejection fraction and E/e’ ratio.
Different types of strain have been used to assess myocardial deformation. LV longitudinal
strain reflects ventricular long axis function, controlled predominantly by subendocardial
fibers [24]. A previous study with Chagas disease found that radial and circumferential strain
could be more accurate for early detection of myocardial involvement than longitudinal strain
[25]. Furthermore, when the LV becomes enlarged and more spherical in dilated cardiomyop-
athy, the contribution from circumferential shortening will increase further relative to longitu-
dinal shortening. Radial strain results from the combination of longitudinal and
circumferential fibre shortening and, therefore, may be a better measure of myocardial defor-
mation alone or in combination [24].
Table 3. Predictors of adverse cardiac events in patients with dilated cardiomyopathy: Univariate analysis.
Variable Without events
(n = 86)
With events
(n = 26)
HR (95% CI) P
Age (years) 55.9 ± 11.7 58.6 ± 21.1 1.004 (0.968–1.042) 0.824
Male gender (n/%) 53 (62) 10 (38) 0.413 (0.182–0.935) 0.034
NYHA class III/IV (n/%) 9 (10) 7 (27) 1.618 (0.635–4.119) 0.313
LV ejection fraction (%) 41.8 ± 9.3 33.2 ± 8.8 0.936 (0.900–0.973) 0.001
E/e’ ratio 9.4 ± 4.9 14.9 ± 6.1 1.088 (1.036–1.143) 0.001
LA volume index (mL/m2) 35.4 ± 13.2 50.9 ± 20.9 1.030 (1.012–1.048) 0.001
RV systolic velocity (cm/s)� 11.9 ± 2.9 10.4 ± 2.9 0.866 (0.738–1.016) 0.077
Speckle tracking strain
Longitudinal strain (%) 12.7 ± 4.3 10.2 ± 3.9 0.879 (0.784–0.985) 0.026
Radial strain (%) 17.4 ± 8.5 12.3 ± 6.4 0.917 (0.856–0.982) 0.013
Circumferential (%) 10.6 ± 3.8 8.9 ± 4.3 0.915 (0.814–1.028) 0.134
Longitudinal RV strain (%) 15.1 ± 4.9 12.9 ± 4.3 0.935 (0.848–1.032) 0.185
�Peak systolic velocity at the tricuspid annulus
HR = hazard ratio, LA = left atrial; LV = left ventricular; NYHA = New York Heart Association; RV = right ventricular
https://doi.org/10.1371/journal.pone.0221028.t003
Table 4. Multivariable Cox proportional-hazards analysis for predicting adverse cardiac events in the overall patient population with dilated cardiomyopathy.
Variables� Hazard ratio† 95% CI Z value P value
LV ejection fraction (%) 0.839 0.760–0.925 -3.532 0.0004
E/e’ ratio 1.060 1.015–1.108 2.638 0.0083
LV global longitudinal strain (%) 1.365 1.106–1.686 2.892 0.0038
� Fitted model estimates corrected by shrinkage factor of 0.8139
† Shrinkage hazard ratio
https://doi.org/10.1371/journal.pone.0221028.t004
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Speckle tracking echocardiography in Chagas disease
Myocardial deformation imaging with echocardiography can be measured using tissue Dopp-
ler imaging and 2- and 3-dimensional speckle tracking echocardiography [14, 22]. Tissue
Doppler-derived strain has a number of limitations, and strain measurements based on speckle
tracking have become a method of choice to assess myocardial deformation.
In the setting of Chagas disease, the traditional assessment of regional contractile function
relies on a qualitative visual estimation of regional thickening and contraction. Speckle track-
ing echocardiography has allowed for the increasing recognition of subclinical myocardial dys-
function, particularly in patients in the indeterminate form of Chagas disease [15, 25–28]. A
previous study in asymptomatic patients with Chagas disease with normal ECG demonstrated
reduced LV strain compared to controls, especially global radial strain at the basal segments of
inferior, inferoseptal, and inferolatateral walls [27]. Similarly, another study with patients in
indeterminate form of Chagas disease had lower global radial strain in the inferior segments
compared to controls [25]. In contrast, Gomes et al [16] including 125 Chagas disease patients
found no differences in global longitudinal, circumferential, and radial LV speckle-tracking
strain among controls, patients in the indeterminate form, and asymptomatic patients with
isolated changes on the ECG. However, patients who had myocardial fibrosis on cardiac mag-
netic resonance imaging presented with lower global longitudinal, circumferential and radial
speckle tracking strain than those without cardiac fibrosis despite similar LV systolic function
by ejection fraction [16]. In another study including patients in different forms of chronic
Chagas disease a high correlation between longitudinal global speckle tracking strain with
myocardial fibrosis was found. [15] Nevertheless, after adjustment for LV ejection fraction,
speckle tracking strain was not associated with myocardial fibrosis [15].
Different from previous studies, the present study enrolled only Chagas disease patients
with dilated cardiomyopathy and systolic dysfunction and compared it to a control population
with non-Chagas dilated cardiomyopathy, defined by negative anti-T.cruzi serology. A homog-
enous population was selected to search for differences in the pattern of myocardial strain
Fig 5. Event-free survival rate according to left ventricular global longitudinal strain (LVGLS) cut-off. Kaplan–
Meier time curves stratified according to an LVGLS cut-off of –12%. Those with an LVGLS� -12% were significantly
more likely to be free of the event compared with those with an LVGLS of> - 12% or more.
https://doi.org/10.1371/journal.pone.0221028.g005
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potentially related to myocardial fibrosis. The finding of reduced radial strain despite higher
LV ejection fraction in CDC supports the concept that radial strain appears to be more accu-
rate to detect myocardial dysfunction than longitudinal strain in the setting of Chagas disease.
Regueiro et al [10] reported that in CDC, 52% of the patients had myocardial fibrosis and/
or necrosis, with heterogeneous pattern of involvement including subendocardial, midwall,
subepicardial, and transmural. Since radial thickening is determined by both circumferential
and longitudinal myocardial fibre shortening, it expresses better the overall ventricular func-
tion in CDC.
Prognostic value of LV longitudinal strain
While strain by speckle-tracking has been shown to have clinical utility in the identification of
systolic dysfunction in the context of normal ejection fraction, there is also a growing body of
evidence to indicate that strain may also have prognostic value in patients with heart failure
[29–31]. Ejection fraction, derived from changes in ventricular volumes, does not necessarily
reflect myocardial muscle or sarcomeric shortening. As such myocardial strain and ejection
fraction (which is more of a measure of global function) could be seen as distinct entities [32]
Although myocardial strain is a comprehensive indicator of LV function, few data are avail-
able regarding its prognostic implications in Chagas disease. Previous studies have examined
the LV strain as a potential predictor for Chagas disease progression [27, 28]. In a study includ-
ing a wide spectrum of clinical presentation of patients with Chagas disease, global LV longitu-
dinal and radial strain progressively decreased along with increased of brain natriuretic
peptide levels as diastolic dysfunction severity increased [33]. In our study, we assessed the
association between LV global longitudinal strain and the occurrence of cardiovascular events,
regardless of LVEF and diastolic filling pressures, which are well-established prognostic mark-
ers in dilated cardiomyopathy. Our results suggest that measurement of LV global longitudinal
strain can improve risk stratification in these patients and may contribute to better decision
making for further treatment in this population.
Study limitations
Patients with Chagas cardiomyopathy were referral for assessment of heart disease at the time
of positive serological tests whereas those with IDC had the diagnosis after the onset of symp-
toms. It may explain the more severe clinical presentation of IDC than CDC. The small num-
ber of events limited a stratified analysis according to the etiology of the cardiomyopathy.
Although strain is considered relative load independent, systolic strain is largely an ejection
phase index, which is substantially dependent on preload and afterload. Additionally, cardiac
magnetic resonance to assess myocardial fibrosis was not performed in our study.
Conclusions
Speckle tracking echocardiographic deformation indices were abnormal in patients with
dilated cardiomyopathy. Patients with Chagas cardiomyopathy presented similar STE values
with idiopathic cardiomyopathy, after adjustment for the degree of LV systolic dysfunction.
LV longitudinal strain was a powerful predictor of cardiac events in patients with dilated car-
diomyopathy, which provides prognostic information beyond to LV ejection fraction and E/e’
ratio.
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